LK
Therapeutic Areas
Takara Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TBI-1501 | Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) | Phase I/II |
| TBI-1401 | Glioma (Malignant Brain Tumor) | Phase I/II |
| Regenerative Medicine Programs | Cartilage / Osteoarthritis | Preclinical / Early Clinical |
| rAAV-based Gene Therapy Programs | Undisclosed Rare Diseases | Discovery / Preclinical |